Genzyme CEO Henri Termeer - CEO pay report
Henri A. Termeer - Genzyme
Total Compensation: $14.6 million
Details: Termeer spent part of 2007 convincing investors that, unlike Biogen Idec and MedImmune, Genzyme wasn't a good takeover target. For his efforts, Termeer gained $1.5 million in base salary--a 5 percent increase over 2006--about $2.1 million in bonuses, $10 million in option awards, and $105,773 in other expenses like travel, insurance and 401(k) contributions.
Genzyme News:
Genzyme on buyouts: Thanks but no thanks
Icahn sells Genzyme stock
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
